NHS rolls out life-saving arthritis drug to treat COVID

NHS rolls out life-saving arthritis drug to treat COVID The NHS is rolling out a cutting-edge, life-saving COVID treatment from today, which is proven to save lives when given to the most seriously ill COVID patients in hospital.

The RECOVERY trial carried out through the NHS found that 13% fewer severely ill patients died of COVID when treated with arthritis drug baricitinib compared to existing treatment options.

Typically used to treat arthritis to reduce pain and inflammation, baricitinib can now be given to hospitalised COVID patients in addition to current treatments, and clinical studies show that this can provide benefits on top of existing treatment. NHS England

See also:

• NHS delivers more than half of spring boosters as latest invites land NHS England
• National flu and COVID-19 surveillance reports published UK Health Security Agency